Tag
Hibsago
-
FDA Approves Hibsago, a 24-Week Shot That Lets Some Hepatitis B Patients Stop
GSK’s bepirovirsen is the first antisense drug approved for chronic hepatitis B. In trials, 19% of patients kept the virus controlled after…
Tag
GSK’s bepirovirsen is the first antisense drug approved for chronic hepatitis B. In trials, 19% of patients kept the virus controlled after…